Anteilseigner
Deka Investment GmbH (79,21 %) Shenzhen Hepalink Pharm (6,65 %) The Vanguard Group, Inc. (1,49 %) BMO Asset Management Corp. (1,44 %) Bruce Jeffrey Wendel (0,85 %) Geode Capital Management LLC (0,81 %) BlackRock Fund Advisors (0,73 %) Wells Fargo Advisors Financial Network LLC (0,73 %) Tower Research Capital LLC (0,17 %) UBS Securities LLC (0,07 %) Morgan Stanley Smith Barney LLC (Investment Management) (0,02 %) Strategic Advisers LLC (0,00 %) Securities America Advisors, Inc. (0,00 %) Merrill Lynch, Pierce, Fenner & Smith, Inc. (Invt Mgmt) (0,00 %) Wells Fargo Bank, NA (Private Banking) (0,00 %) Blue Bell Private Wealth Management LLC (0,00 %) RBC Dominion Securities, Inc. (0,00 %)
Kontakt
GT Biopharma Inc.
Marina Blvd., Suite 100 8000
94005 Brisbane